Taking part in a research trial that could save millions of women: Our Oncology and Research teams are working in partnership with The University of Manchester and Douglas Pharmaceuticals to develop new treatment of early stage cervical cancer. The research is looking into whether a drug, commonly used to treat HIV, might prevent early stage cervical cancer. Dr Pierre Martin-Hirsch, our Consultant Gynaecological Oncologist and Director of Research and Innovation, will be leading the clinical trial in the UK; he said: “This is a really exciting project and something that I am incredibly proud to be involved in. This new treatment could offer hope for millions of women across the world who are at risk of cervical cancer. The clinical trial to try and develop this treatment is due to start in early 2018.
New state-of-the-art cancer robot arrives: We have taken delivery of a new state of the art robot that will improve outcomes for patients with cancer. Our Regional Specialised Cancer Centre is the first hospital in the north of England to have the latest advanced robotic surgical system, which will treat patients from Lancashire and South Cumbria who have bowel, gastrointestinal, urological and gynaecological cancers. The centre is also just one of three in the country, and the only one in the North West, to be able to provide treatment for upper gastrointestinal cancer using this new robot. The robot can bend and rotate 360 degrees, making it much easier for our surgeons to access parts of the body that are difficult to reach, and undertake complex procedures using keyhole incisions rather than open surgery, reducing the risk of complications and enabling a speedier recovery. Our cancer surgeons will now undertake five weeks of bespoke training before visiting world renowned centres in Europe to complete their learning and practise skills. Pierre Martin-Hirsch, one of our Consultant Gynaecological Oncologists said, “The whole team at the Regional Specialised Cancer Centre is excited by the arrival of the new robot, and are looking forward to completing our training so we can offer the very latest treatment to our patients. This new version of the robot will put us at the top of the league for cervical cancer treatment as well as many other cancers.” Mark Pugh, our Medical Director, said: “We are delighted to be the first hospital in the north of England to secure the latest in robotic technology, and we are proud to be leading the way in cancer treatment. This new equipment will help us to continue to provide the very best care for our patients and we thank the Rosemere Cancer Foundation for their support in helping us to do that.” Rosemere Cancer Foundation has launched a fundraising campaign to pay for the robot, which has been delivered to the our Regional Specialised Cancer Centre, so that the latest cancer treatment can be offered to patients immediately. In future, the centre will aim to become the European training hub for the advancement of robotic surgery. If you would like to make a donation to the Rosemere Cancer Foundation’s 20th anniversary appeal, which is raising funds to pay for the robot, visit www.rosemere.org.uk
Cancer robot collage